Statistics from Altmetric.com
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Body dysmorphic disorder (BDD) typically emerges during adolescence, affects approximately 2% of the general population and is highly impairing. Despite its prevalence and impact, awareness of BDD remains poor and the condition often goes undiagnosed and untreated.1 Cognitive–behavioural therapy (CBT) and selective serotonin reuptake inhibitors (SSRIs) are effective treatments for BDD and recommended as the first-line interventions.2 However, little is known about the accessibility of these treatments within the UK or among young people specifically. We conducted a case note review to examine the treatment histories of young people referred to a tertiary care outpatient clinic for BDD and obsessive-compulsive disorder (OCD) in the UK. We hypothesised that: (a) contrary to the National Institute for Health and Care Excellence guidelines …
Contributors All authors contributed to the conception and writing of this study. RR-Z additionally contributed to data cleaning. GK undertook the analyses and wrote the first draft of the manuscript.
Funding The authors have not declared a specific grant for this research from any funding agency in the public, commercial or not-for-profit sectors.
Competing interests None declared.
Provenance and peer review Not commissioned; externally peer reviewed.